Currently, Conduit Pharmaceuticals Inc’s (CDT) stock is trading at $0.26, marking a gain of 2.35% from last night’s close. At this price, the stock is -98.97% below its 52-week high of $25.00 and 21.80% above its 52-week low of $0.21. Based on the past 30-day period, the stock price is -86.00% below the high and +19.76% above the low.
The 200-day Simple moving average is often placed more emphasis on by traders because of daily price changes. Investors will use the SMA-200 in different situations in trading activity as a key indicator to determine their support and resistance levels, and at the moment, CDT’s SMA-200 is $2.8625.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
How does Conduit Pharmaceuticals Inc (CDT) stock rate among analysts? Buy, sell, or hold?
The key to trading is to concentrate on the future rather than on the past. During uncertain times, it can be hard to make decisions. The analysts who understand how a market works are usually the most accurate at forecasting its future. The ratings are commonly aggregated into a single number between 1 and 5. Buy or strong buy is scored 5, outperform is scored 4, hold is scored 3, underperform is scored 2 and strong sell is 1.
Conduit Pharmaceuticals Inc (NASDAQ: CDT) Ownership Details
I will give a breakdown of the key shareholders in Conduit Pharmaceuticals Inc (CDT). Recent figures show that the company’s insiders hold 86.65% of shares. A total of 24 institutional investors hold shares in the company, making 2.24% of its stock and 16.81% of its float.
Mar 31, 2024 , it was reported that the Company’s largest institutional holder is Barclays Plc holding total of 804.29 shares that make 1.09% of the company’s total number of shares and are currently priced at 0.21 million.
The securities firm Vanguard Group Inc holds 207.89 shares of CDT, making it the second largest institutional shareholder. Taking this into account, the holding percentage comes to 0.28% , and the holding percentage of shares is valued at 53220.0.
An overview of Conduit Pharmaceuticals Inc’s technicals
In order to learn about trade movements and investor behavior, it is best to analyze the short, medium, and long term technical indicators along with the average volume of a stock. A 20-day average of the stock’s daily volume suggests Conduit Pharmaceuticals Inc (CDT) traded 6,845,853 shares per day, with a moving average of $0.7992 and price change of -1.4373. With the moving average of $2.0079 and a price change of -2.7473, about 2,770,267 shares changed hands on average over the past 50 days. Finally, CDT’s 100-day average volume is 1,400,038 shares, alongside a moving average of $2.5735 and a price change of -2.5773.
